Company news

Fagron SA news in 2026

Fagron SA's news releases, calls and decks from 2026, newest first.

View company

Regulated information: Fagron increases share capital through exercise subscription rights

September 21, 2026

Regulated information: Fagron delivers strong H1 2026 performance with 16% topline growth and reiterates FY 2026 guidance

July 30, 2026

NV, - Disclosure of transparency notifications from BlackRock, Inc.

May 19, 2026

Fagron N update on FDA communication regarding the November 2025 inspection at Boston

May 15, 2026

Fagron shareholders approve all proposed resolutions at the General Meetings

May 11, 2026

NV, - Disclosure of transparency notification from BlackRock, Inc.

April 29, 2026

Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America

April 16, 2026

Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026

April 10, 2026

Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth

April 9, 2026

Fagron increases share capital through exercise subscription rights

March 31, 2026

NV, - Disclosure of a transparency notification from Aberdeen Group plc

March 19, 2026

Fagron publishes its Annual Report 2025

March 6, 2026

Fagron completes acquisition of Vepakum

March 3, 2026

Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA

February 26, 2026

Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA

February 12, 2026

Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary

February 5, 2026

Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America

January 12, 2026

Fagron announces the completion of Purifarma

January 6, 2026

Calls in 2026

Decks in 2026